Cargando…
The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death
Cancer immunotherapy is a strategy that is moving to the frontier of cancer treatment in the current decade. In this study, we show evidence that 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs), act as immunogenic cell death (ICD) inducers, stimulating an antitumor response...
Autores principales: | Duan, Xiao-Chuan, Peng, Li-Yuan, Yao, Xin, Xu, Mei-Qi, Li, Hui, Zhang, Shuai-Qiang, Li, Zhuo-Yue, Wang, Jing-Ru, Feng, Zhen-Han, Wang, Guang-Xue, Liao, Ai, Chen, Ying, Zhang, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079060/ https://www.ncbi.nlm.nih.gov/pubmed/33866918 http://dx.doi.org/10.1080/10717544.2021.1909180 |
Ejemplares similares
-
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo
por: Duan, Xiao-Chuan, et al.
Publicado: (2018) -
The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug
por: Song, Ping, et al.
Publicado: (2016) -
Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression
por: Annilo, Tarmo, et al.
Publicado: (2009) -
Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model
por: Yang, Cuiping, et al.
Publicado: (2015) -
Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
por: Du, Ruo, et al.
Publicado: (2014)